The markets traded flat during the midday with the Dow edging up 5 points to 13,258 after a disappointing slip in consumer sentiment. Nasdaq added a point to 3058.
On the upside
Shares of Frontline (NYSE: FRO) climbed after Dahlman Rose wrote that oil tanker rates are expected to be "very well supported in the coming weeks."
Elan's (NYSE: ELN) is expected to release Phase 3 trial data for its Azheimer's Disease treatment bapineuzumab in July.
Shares of Amarin (Nasdaq: AMRN) continued rising over expectations that the U. S. Patent and Trademark will grant a patent for the biopharmaceutical's cancer treatment AMR-101.
On the downside
The 2011 compensation package for Synovus Financial (NYSE: SNV) president and chief executive Kessel D. Sterlling soared 66%.
SMF Energy (Nasdaq: FUEL) cited sharply lower sales and earnings projections for indefinitely suspending its quarterly dividend.
SunTrust downgraded Abraxas Petroleum (Nasdaq: AXAS) to a Neutral rating.
In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks eased a point to 830.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here